US 8168798
Caspase inhibitor prodrugs
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8168798 (Caspase inhibitor prodrugs) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18